147 related articles for article (PubMed ID: 28521171)
21. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
[TBL] [Abstract][Full Text] [Related]
22. Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group.
Pasqualini C; Furtwängler R; van Tinteren H; Teixeira RAP; Acha T; Howell L; Vujanic G; Godzinski J; Melchior P; Smets AM; Coulomb-L'Hermine A; Brisse H; Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Graf N; Verschuur AC
Eur J Cancer; 2020 Mar; 128():38-46. PubMed ID: 32109849
[TBL] [Abstract][Full Text] [Related]
23. An update on the management of Wilms' tumour.
Ahmed HU; Arya M; Tsiouris A; Sellaturay SV; Shergill IS; Duffy PG; Mushtaq I
Eur J Surg Oncol; 2007 Sep; 33(7):824-31. PubMed ID: 17317082
[TBL] [Abstract][Full Text] [Related]
24. A phase II study of ifosfamide in the treatment of relapses in Wilms' tumor.
Tournade MF
Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S31-3. PubMed ID: 2547529
[TBL] [Abstract][Full Text] [Related]
25. Volumetric assessment of unaffected parenchyma and Wilms' tumours: analysis of response to chemotherapy and surgery using a semi-automated segmentation algorithm in children with renal neoplasms.
Rickard M; Fernandez N; Blais AS; Shalabi A; Amirabadi A; Traubici J; Lee W; Gleason J; Brzezinski J; Lorenzo AJ
BJU Int; 2020 May; 125(5):695-701. PubMed ID: 32012416
[TBL] [Abstract][Full Text] [Related]
26. Bilateral Wilms' tumors: a single-center experience with 19 cases.
Millar AJ; Davidson A; Rode H; Numanoglu A; Hartley PS; Daubenton JD; Desai F
J Pediatr Surg; 2005 Aug; 40(8):1289-94. PubMed ID: 16080934
[TBL] [Abstract][Full Text] [Related]
27. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
van Dalen EC; Raphaël MF; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2014 Sep; (9):CD006647. PubMed ID: 25188452
[TBL] [Abstract][Full Text] [Related]
28. Bilateral Wilms' tumor.
Kullendorff CM; Wiebe T
Pediatr Surg Int; 1999; 15(1):46-9. PubMed ID: 9914355
[TBL] [Abstract][Full Text] [Related]
29. Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience.
Vujanić GM; Apps JR; Moroz V; Ceroni F; Williams RD; Sebire NJ; Pritchard-Jones K
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28383760
[TBL] [Abstract][Full Text] [Related]
30. Pharmacotherapeutic Management of Wilms Tumor: An Update.
Oostveen RM; Pritchard-Jones K
Paediatr Drugs; 2019 Feb; 21(1):1-13. PubMed ID: 30604241
[TBL] [Abstract][Full Text] [Related]
31. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Green DM; Beckwith JB; Breslow NE; Faria P; Moksness J; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S
J Clin Oncol; 1994 Oct; 12(10):2126-31. PubMed ID: 7931483
[TBL] [Abstract][Full Text] [Related]
32. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
Stefanowicz J; Sierota D; Balcerska A; Stoba C
Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
[TBL] [Abstract][Full Text] [Related]
33. Optimal neoadjuvant chemotherapy duration in Wilms tumour with intravascular thrombus: A literature review and evidence from SIOP WT 2001 trial.
Morris L; Squire R; Sznajder B; van Tinteren H; Godzinski J; Powis M
Pediatr Blood Cancer; 2019 Nov; 66(11):e27930. PubMed ID: 31339231
[TBL] [Abstract][Full Text] [Related]
34. Synchronous bilateral Wilms' tumor.
Nawaz A; Mpofu C; Shawis R; Matta H; Jacobsz A; Kassir S; Al Salem A
Pediatr Surg Int; 1999; 15(1):42-5. PubMed ID: 9914354
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy and safety of the WT-2009 chemotherapy protocol in treatment of Wilms' tumor in children].
Guo X; Lin C; Gao J; Zhou CY; Li Q; Zhu YP
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Mar; 17(3):262-5. PubMed ID: 25815497
[TBL] [Abstract][Full Text] [Related]
36. Wilms' tumour: a comparison of surgical aspects in patients with or without pre-operative chemotherapy.
Safdar CA; Aslam M; Awan SH; Ahmed I; Badshah S
J Coll Physicians Surg Pak; 2006 Aug; 16(8):521-4. PubMed ID: 16899180
[TBL] [Abstract][Full Text] [Related]
37. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ
J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
[TBL] [Abstract][Full Text] [Related]
38. Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms' tumor--a phase II study by the French Society of Pediatric Oncology.
Pein F; Tournade MF; Zucker JM; Brunat-Mentigny M; Deville A; Boutard P; Dusol F; Gentet JC; Legall E; Mechinaud F
J Clin Oncol; 1994 May; 12(5):931-6. PubMed ID: 8164044
[TBL] [Abstract][Full Text] [Related]
39. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S; Haase G; Ritchey M; Kelalis P; D'Angio GJ
J Clin Oncol; 1998 Dec; 16(12):3744-51. PubMed ID: 9850017
[TBL] [Abstract][Full Text] [Related]
40. Wilms' tumour and chemotherapeutic access.
Yasri S; Wiwanitkit V
Afr J Paediatr Surg; 2015; 12(3):208. PubMed ID: 26612130
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
